HighTower Advisors’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
AI
BIP
HighTower Advisors's PBH Position: Q2 2026 in Review
HighTower Advisors reduced its Prestige Consumer Healthcare (PBH) stake by 52% in Q2 2026, selling an estimated $381K and leaving 6,826 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #3155.
HighTower Advisors first reported a position in PBH in Q3 2019 and has held it in 25 quarters since. The position peaked at $2.85M in Q2 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- HighTower Advisors held 6,826 shares of Prestige Consumer Healthcare worth $323K as of Q2 2026.
- HighTower Advisors sold 7,405 Prestige Consumer Healthcare shares in Q2 2026, an estimated $381K.
- Prestige Consumer Healthcare made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3155 holding.
- HighTower Advisors first reported a position in Prestige Consumer Healthcare in Q3 2019 and has held it in 25 quarters since.
- HighTower Advisors's Prestige Consumer Healthcare position peaked at $2.85M in Q2 2025.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.